Science Center Ventures

Taurus Vascular is a medical device company dedicated to enhancing long-term outcomes for patients suffering from aortic aneurysms. The company is focused on transforming the standard of care by developing innovative medical device technology aimed at addressing the complications associated with endoleaks. This technology is designed to facilitate accelerated shrinkage of the aneurysm sac following endovascular aortic aneurysm repair (EVAR). By improving the effectiveness of treatment, Taurus Vascular aims to significantly enhance patient outcomes in the healthcare sector.

AB Fertitlity develops products for reproductive medicine.

EmpiricaLab develops an online learning platform tailored for healthcare teams. It facilitates peer learning through collaborative authoring, sharing of work-relevant content, and a work-integrated learning curriculum.

MTDS Solution is a company focused on enhancing health and wellness through innovative service offerings. It provides resources aimed at reducing the operational burden on medical institutions while also serving the broader community. The company has developed fully automated kiosks for polymerase chain reaction (PCR) testing, which streamline the testing process for various health concerns. These kiosks enable patients to conduct a wide range of tests, including those for influenza, sexually transmitted infections, blood-borne pathogens, genetic conditions, and drug use. The integration of these kiosks with a user-friendly mobile application further supports patients in managing their health effectively and conveniently.

Steradian Technologies is a biotech company focused on developing innovative, noninvasive diagnostic solutions for infectious diseases. The company has created a rapid COVID-19 detection test that delivers results in just 30 seconds by utilizing a unique focal point projection system that emulates human eyesight. This advanced technology employs photonics to identify pathogens in breath samples, bypassing the need for traditional laboratory equipment and lengthy procedures. By offering a portable diagnostic method that achieves high accuracy in detecting bacteria, viruses, and biomarkers, Steradian Technologies aims to transform patient care and enable clinicians to provide quicker, more precise diagnoses.

Prana Thoracic, Inc., based in Houston, is a medical device startup focused on developing innovative solutions for the early intervention of lung cancer, the leading cause of cancer-related deaths in the United States. The company aims to address the critical challenges in lung cancer screening and diagnosis, where only a small percentage of cases are detected at an early stage. Prana Thoracic's advanced electrosurgical instrument utilizes bipolar radiofrequency energy to perform minimally invasive procedures, enabling physicians to capture and diagnose small, hard-to-reach lung nodules while reducing the risk of complications. By enhancing the tools available for surgical oncology in lung cancer, Prana Thoracic seeks to improve patient outcomes and capitalize on recent advancements in screening guidelines, ensuring early intervention opportunities are not missed.

BioCurie is developing an artificial intelligence software platform to better cell and gene therapy.

Trace Orthopedics specializes in the development of innovative medical devices for tendon reattachment without the need for traditional surgery. The company has created a minimally invasive procedure that utilizes a specialized device designed to repair partially torn tendons by inserting a needle through the skin. This technique allows for the secure attachment of tendons back to bone, eliminating the need for general anesthesia or an operating room visit. As a result, patients benefit from quicker recovery times and reduced healthcare costs. Trace Orthopedics aims to enhance patient outcomes and streamline the treatment process in orthopedic care.

Rubitection is a medical technology company that develops AI-powered skin health monitoring and care-management solutions for wound care, dermatology, and cosmetic applications. The company offers a handheld system and related assessment tools designed to detect early signs of skin breakdown, including bedsores, diabetic foot ulcers, and other chronic dermatological conditions, enabling caregivers, physicians, and nurses to monitor risk and intervene early. Its platform provides data-driven insights to support assessment, prevention, and treatment of chronic wounds such as diabetic foot ulcers, vascular leg ulcers, psoriasis, and eczema, with the aim of improving patient outcomes and reducing care costs. Rubitection positions itself as a global standard system for skin health monitoring and care management, and is based in Pittsburgh, Pennsylvania.

Aware.ai uses AI to create virtual support communities for women and connect them to resources during pregnancy.

Opal HTM enhances hospital safety and efficiency by employing innovative technologies to revolutionize medical equipment management and maintenance.

Gray Oncology Solutions aims to optimize cancer treatment workflows by developing software that personalizes each patient's journey, statistically improves clinical outcomes, reduces wait-times, increases throughput, and enhances overall patient care.

Allevi is a pioneering company that develops innovative tools for designing and engineering 3D tissues. It specializes in desktop 3D bioprinters capable of creating functional, three-dimensional living tissues, alongside proprietary bioinks composed of collagen and hyaluronic acid. Allevi's cloud-based platform, Bioprint Online, allows users to design structures, select materials, and monitor the printing process. Its products cater to a diverse clientele, including researchers in tissue engineering, regenerative medicine, material science, and cell biology, as well as industrial and pharmaceutical companies involved in drug testing and development. Additionally, Allevi sells its bioinks online. Founded in 2014 and headquartered in Philadelphia, Pennsylvania, the company was previously known as BioBots, Inc.

StageMark develops and markets inflammatory diseases identification and monitoring solutions. The company's product, CB-CAPs, enables user to analyze complement products bound to various blood cell types such as erythrocytes, platelets, reticulocytes, and lymphocytes. StageMark, Inc. was founded in 2004 and is headquartered in Pittsburgh, Pennsylvania.